Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkw439
Abstract: ical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol 2010; 27: 221–4. 5 Wirden M, Tubiana R, Fourati S et al. Upgraded Cobas Ampliprep-Cobas Taqman version 2.0 HIV-1 RNA quantification assay…
read more here.
Keywords:
efficacy elvitegravir;
hiv;
elvitegravir cobicistat;
tenofovir disoproxil ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkx246
Abstract: Objectives To assess HIV-1 post-exposure prophylaxis (PEP) non-completion at day 28, comparing ritonavir-boosted lopinavir versus cobicistat-boosted elvitegravir as a single-tablet regimen (STR), using tenofovir disoproxil fumarate/emtricitabine with both of these therapies. Methods A prospective, open,…
read more here.
Keywords:
elvitegravir cobicistat;
ritonavir;
cobicistat;
versus ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.05125-22
Abstract: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide as a maintenance therapy showed durable and high rates of viral suppression for HIV/HBV-coinfected patients, with only 5.1% and 2.2% of patients having HBV DNA of ≥20 IU/mL and HIV RNA of ≥50 copies/mL,…
read more here.
Keywords:
hiv hbv;
elvitegravir cobicistat;
cobicistat emtricitabine;
coinfected patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "African Health Sciences"
DOI: 10.4314/ahs.v21i4.13
Abstract: Background Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil (E/C/F/TDF) in treatment-naïve and experienced patients with HIV infection was demonstrated in phase 3 trials. The primary objective of this study was to evaluate effectiveness and safety of E/C/F/TDF in…
read more here.
Keywords:
effectiveness safety;
elvitegravir cobicistat;
treatment;
real world ... See more keywords